CBIO
Crescent Biopharma
CBIO
CBIO
41 hedge funds and large institutions have $135M invested in Crescent Biopharma in 2025 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
22% less capital invested
Capital invested by funds: $174M → $135M (-$39M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
41
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$8.73M | |
| 2 | +$8.35M | |
| 3 | +$5.09M | |
| 4 |
BlackRock
New York
|
+$1.37M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.31M |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$4.22M | |
| 3 | -$3.48M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$2.65M |
| 5 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$2.4M |